Pharminackx
0744.671.869 · rovalta.com · 25/09/2026
Pharminackx
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPharminackx is a Private limited company incorporated in 2020. Its main activity is: Activities of holding companies. Its registered office is in Alken.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0744.671.869
- Incorporation
- 03/03/2020
- Legal form
- Private limited company
- Registered office
- O. L. Vrouwstraat 92
3570 Alken · FlandreSee on map - Contributed capital
- 5 000,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 5 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 21,9 k € | -16.6% | 26,2 k € | -17.1% | 31,6 k € | -2.5% | 32,5 k € | -47.0% | 61,2 k € |
| EBITDA | 18,8 k € | -18.8% | 23,2 k € | -19.8% | 28,9 k € | -3.9% | 30 k € | -47.6% | 57,4 k € |
| Operating result | 18,8 k € | -18.8% | 23,2 k € | -19.8% | 28,9 k € | -3.9% | 30 k € | -47.6% | 57,4 k € |
| Net result | 10,6 k € | -21.7% | 13,5 k € | -22.5% | 17,5 k € | +99.9% | 8,7 k € | -58.2% | 20,9 k € |
| Balance sheet | |||||||||
| Equity | 76,2 k € | +16.2% | 65,6 k € | +26.0% | 52,1 k € | +50.5% | 34,6 k € | +33.7% | 25,9 k € |
| Total assets | 940,4 k € | +0.1% | 939,3 k € | +0.6% | 933,4 k € | -2.7% | 958,8 k € | +0.3% | 956,1 k € |
| Cash | 1,1 k € | +2302% | 44,1 € | -97.7% | 1,9 k € | -48.6% | 3,8 k € | +258% | 1,1 k € |
| Debts | 864,2 k € | -1.1% | 873,7 k € | -0.9% | 881,3 k € | -4.6% | 924,2 k € | -0.6% | 930,2 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 2 ended
Active mandates
Ended mandates
Other companies at this address
O. L. Vrouwstraat 92 3570 Alken| Company | CBE no. |
|---|---|
Apotheek Terkoest● Active | 0479.685.586 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 03/03/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 22 months |
| Filing date | 08/07/2026 | 24/06/2025 | 22/07/2024 | 31/08/2023 | 15/07/2022 |
| General meeting | 19/06/2026 | 20/06/2025 | 21/06/2024 | 16/06/2023 | 17/06/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 5 filingsValuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other05/03/2020RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202510,6 k €↓
- 2024Annual accounts 202413,5 k €↓
- 2023Annual accounts 202317,5 k €↑
- 2022Annual accounts 20228,7 k €↓
- 2021Annual accounts 202120,9 k €
- 03/03/2020IncorporationPrivate limited company